Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
1.99M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
455
-
Shares change
-
+455
-
Total reported value, excl. options
-
$1.83K
-
Value change
-
+$1.83K
-
Number of buys
-
4
-
Price
-
$4.03
Significant Holders of Bone Biologics Corp - Common stock, par value $0.001 per share (BBLG) as of Q2 2025
4 filings reported holding BBLG - Bone Biologics Corp - Common stock, par value $0.001 per share as of Q2 2025.
Bone Biologics Corp - Common stock, par value $0.001 per share (BBLG) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 455 shares
of 1.99M outstanding shares and own 0.02% of the company stock.
Largest 4 shareholders include Tower Research Capital LLC (TRC) (200 shares), CLEAR STREET LLC (138 shares), UBS Group AG (113 shares), and BANK OF AMERICA CORP /DE/ (4 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.